Gao, Botao
Sakaguchi, Katsuhisa
Ogawa, Tetsuya
Kagawa, Yuki
Kubo, Hirotsugu
Shimizu, Tatsuya http://orcid.org/0000-0001-7601-4239
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP18im0302706)
Guangdong Academy of Sciences (2020GDASYL-20200102005)
Guangdong Academy of Sciences (2017GDASCX-0103)
Article History
Received: 4 June 2020
Revised: 22 August 2020
Accepted: 26 August 2020
First Online: 30 January 2021
Compliance with ethical standards
:
: Tatsuya Shimizu is a member of the scientific advisory board and a stakeholder of CellSeed Inc. Tetsuya Ogawa, Yuki Kagawa and Hirotsugu Kubo are employees of Nihon Kohden Corporation. Tokyo Women’s Medical University was receiving research funds from CellSeed Inc. and Nihon Kohden Corporation.
: There are no animal experiments carried out for this article.